A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)

Clinical trial NCT07306559 · RECRUITING

Trial details

NCT number: NCT07306559
Sponsor: Boehringer Ingelheim
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Relapsed or Refractory Germ Cell Tumours Advanced Relapsed or Refractory Endometrial Cancer Advanced Relapsed or Refractory Ovarian Cancer

Start date: 2026-04-28
Primary completion: 2029-09-07
Enrollment: 187

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.